1. Home
  2. ARI vs PVLA Comparison

ARI vs PVLA Comparison

Compare ARI & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$10.71

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$81.01

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARI
PVLA
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
ARI
PVLA
Price
$10.71
$81.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
17
Target Price
$10.83
$145.24
AVG Volume (30 Days)
1.5M
248.8K
Earning Date
02-10-2026
03-30-2026
Dividend Yield
9.36%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
$269,296,000.00
N/A
Revenue This Year
$23.46
N/A
Revenue Next Year
$16.31
N/A
P/E Ratio
$12.05
N/A
Revenue Growth
67.16
N/A
52 Week Low
$7.70
$14.68
52 Week High
$11.21
$114.69

Technical Indicators

Market Signals
Indicator
ARI
PVLA
Relative Strength Index (RSI) 63.42 44.66
Support Level $10.59 $74.40
Resistance Level $10.92 $85.05
Average True Range (ATR) 0.26 6.53
MACD 0.03 -0.43
Stochastic Oscillator 71.85 40.74

Price Performance

Historical Comparison
ARI
PVLA

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: